1. Home
  2. SCLX vs TGE Comparison

SCLX vs TGE Comparison

Compare SCLX & TGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$5.57

Market Cap

55.1M

Sector

Health Care

ML Signal

HOLD

TGE

The Generation Essentials Group Class A Ordinary Shares

HOLD

Current Price

$0.92

Market Cap

46.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
TGE
Founded
2011
2023
Country
United States
France
Employees
N/A
166
Industry
Biotechnology: Pharmaceutical Preparations
Newspapers/Magazines
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
55.1M
46.3M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
SCLX
TGE
Price
$5.57
$0.92
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
54.6K
33.3K
Earning Date
04-10-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$30,253,000.00
N/A
Revenue This Year
$122.52
N/A
Revenue Next Year
$186.30
N/A
P/E Ratio
N/A
$2.99
Revenue Growth
N/A
N/A
52 Week Low
$4.20
$0.78
52 Week High
$34.27
$4.40

Technical Indicators

Market Signals
Indicator
SCLX
TGE
Relative Strength Index (RSI) 33.36 54.64
Support Level $5.48 $0.91
Resistance Level $7.77 $1.01
Average True Range (ATR) 0.39 0.05
MACD -0.08 0.01
Stochastic Oscillator 11.55 55.33

Price Performance

Historical Comparison
SCLX
TGE

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

About TGE The Generation Essentials Group Class A Ordinary Shares

The Generation Essentials Group is a media and entertainment company. Its publications L'Officiel and The Art Newspaper publish print editions in a total of nearly 28 countries and territories and digital contents. It operate in the movie production sector having produced various Asia-focused movies. It operate in three operating segments: media and entertainment segment, hotel operations, hospitality and VIP services segment and strategic investment segment. Key revenue is generated from strategic investment segment that is engage in proprietary investments and management of portfolio, including listed and unlisted equity shares investments and movie income right investments.

Share on Social Networks: